MedTrace Logo

Effects of Multiple Intervention on Postmenopausal Women With UI

NCT07324668 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 117

Last updated 2026-01-07

No results posted yet for this study

Summary

Study

The purpose of this clinical trial was to investigate the effects of a multi-intervention approach, including Kegel and Tai Chi exercises, on quality of life, self-efficacy, and urinary incontinence severity in postmenopausal women.

Key Questions the Study Aims to Answer:

How does the multi-intervention approach affect quality of life?

Does the multi-intervention approach affect women's self-efficacy?

How does the multi-intervention approach affect urinary incontinence severity?

How does the frequency of exercises (3 days per week vs. 6 days per week) affect these outcomes?

Do the effects of the intervention change temporally over the 8-week period?

Who is Eligible?

Women aged 45 and over who have gone through menopause

Those who wish to volunteer for the study

Those who have no communication barriers

Those who have not previously received treatment for urinary incontinence

Those who can use a smartphone or WhatsApp

Those who experience urine leakage when coughing or sneezing

Study Application:

The exercises will be administered for 8 weeks.

Participants will be taught how to perform the exercises and will be demonstrated through brochures and videos.

Reminders will be provided during the exercises.

Conditions

Interventions

BEHAVIORAL

Combined Exercise Program

Participants will receive education on urinary incontinence, Kegel and Tai Chi exercises, brochures and videos, and perform exercises 3 days/week for 8 weeks with reminders

BEHAVIORAL

Combined Exercise Program

Participants will receive same education and materials as Group 1 and perform exercises 6 days/week for 8 weeks with reminders.

Sponsors & Collaborators

  • Ondokuz Mayıs University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
45 Years
Max Age
55 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-12-15
Primary Completion
2026-02-15
Completion
2026-02-15

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07324668 on ClinicalTrials.gov